Z-2152-2014Class II
VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific...
bioMerieux, Inc. / initiated 2013-10-14 / Terminated / root cause: packaging
BioMerieux SA began a recall of VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma on . FDA classified it as Class II and gives the reason as "Product is not approved or authorized for distribution in the US". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.
Recall record
- Recall number
- Z-2152-2014
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- bioMerieux, Inc.
- Product
- VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma.
- Product code
- MTF Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
- Reason for recall
- Product is not approved or authorized for distribution in the US.
- Root cause tag
- packaging
- FDA root cause
- Packaging process control
- Action
- A letter was issued on October 14, 2013 to consignees requesting the consignee to check their stock and destroy all kits of the VIDAS TPSA ref. 30428. The letter also requested that the consignee notify their accounts of the recall. An acknowledgment form was also included with the letter which is to be returned to BioMerieux.
- Quantity in commerce
- 1902
- Distribution
- FL, LA, MI, MS, NV, OH, OK, TN, TX
- Product codes and lots
- Lot 1001904130
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2152-2014 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
